by Stacey Johnson | Jul 16, 2021
Here at Signals, we are gearing up for our sixth blog carnival, to be held on Wednesday, August 25, 2021. If you’ve never read one before, Signals’ blog carnival is a collection of posts from thought leaders and influential bloggers all centred around one theme. In...
by Stacey Johnson | Jun 25, 2021
Back in November 2020, California voters approved Proposition 14. That means US$5.5B is being directed to the California Institute for Regenerative Medicine (CIRM) to support promising cell and gene therapy research so the organization can continue the important work...
by Stacey Johnson | Jun 11, 2021
“There’s a party going on right here, a celebration to last throughout the years, so bring your good times and your laughter too, we gonna celebrate your party with you.” – Kool & The Gang, Eumir Deodato June 14, 2021, is the 10-year anniversary of CCRM’s launch....
by Stacey Johnson | May 28, 2021
Cormac McCarthy is a Pulitzer prize-winning author. I am not. What we do have in common is that neither of us is a scientist. But we share a desire to impart good writing tips on the world. Cormac McCarthy’s platform is huge while I’m just happy if I can help anyone...
by Stacey Johnson | May 7, 2021
The incredible, non-stop growth of the global cell and gene therapy market – valued at ~$12 billion by 2025 – means that talent is in high demand. (That estimate does not include tissue engineering, but it still seems low.) While seasoned professionals and those with...
by Laine Bodnar | Apr 23, 2021
The regenerative medicine industry is growing at a break-neck pace. The Alliance for Regenerative Medicine (ARM) recently released its 2020 Annual Report. It provides us with some metrics to illustrate the boom that the field is experiencing. It paints an exciting...
Comments